SK103093A3 - New active compounds - Google Patents

New active compounds Download PDF

Info

Publication number
SK103093A3
SK103093A3 SK1030-93A SK103093A SK103093A3 SK 103093 A3 SK103093 A3 SK 103093A3 SK 103093 A SK103093 A SK 103093A SK 103093 A3 SK103093 A3 SK 103093A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
pyridine
group
mmol
Prior art date
Application number
SK1030-93A
Other languages
English (en)
Slovak (sk)
Inventor
Carian Briving
Marie Elebring
Stig Carlsson
Robert Carter
Thomas Kuhler
Peter Nordberg
Ingemar Starke
Arne Svensson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK103093A3 publication Critical patent/SK103093A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
SK1030-93A 1991-03-27 1992-03-25 New active compounds SK103093A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9100920A SE9100920D0 (sv) 1991-03-27 1991-03-27 New active compounds
PCT/SE1992/000190 WO1992017477A1 (en) 1991-03-27 1992-03-25 New active compounds

Publications (1)

Publication Number Publication Date
SK103093A3 true SK103093A3 (en) 1994-08-10

Family

ID=20382295

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1030-93A SK103093A3 (en) 1991-03-27 1992-03-25 New active compounds

Country Status (30)

Country Link
US (1) US5439917A (ja)
EP (2) EP0509974B1 (ja)
JP (1) JP3122792B2 (ja)
CN (1) CN1067892A (ja)
AP (1) AP309A (ja)
AT (1) ATE175672T1 (ja)
AU (1) AU655634B2 (ja)
BG (1) BG98124A (ja)
CA (1) CA2106880A1 (ja)
DE (1) DE69228142T2 (ja)
DK (1) DK0509974T3 (ja)
ES (1) ES2129039T3 (ja)
FI (1) FI934203A0 (ja)
GR (1) GR3029834T3 (ja)
HU (1) HUT65948A (ja)
IE (1) IE920915A1 (ja)
IL (1) IL101347A0 (ja)
IS (1) IS3827A (ja)
JO (1) JO1704B1 (ja)
MA (1) MA22477A1 (ja)
MX (1) MX9201324A (ja)
NO (1) NO933425L (ja)
NZ (1) NZ241943A (ja)
SE (1) SE9100920D0 (ja)
SK (1) SK103093A3 (ja)
TN (1) TNSN92026A1 (ja)
TW (1) TW198032B (ja)
WO (1) WO1992017477A1 (ja)
YU (1) YU30292A (ja)
ZA (1) ZA921823B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CN1615873A (zh) 1999-12-24 2005-05-18 阿文蒂斯药物有限公司 氮杂吲哚类化合物
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
WO2003082868A1 (en) 2002-03-28 2003-10-09 Eisai Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
DE602004023921D1 (de) 2003-03-10 2009-12-17 Nycomed Gmbh Neues verfahren zur herstellung vonroflumilast
US6981980B2 (en) 2003-03-19 2006-01-03 Phagia Technology Self-inflating intragastric volume-occupying device
EP1628975A2 (en) 2003-05-16 2006-03-01 Eisai Co., Ltd. Jnk inhibitors
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
GB0516156D0 (en) 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
KR102348222B1 (ko) * 2020-05-15 2022-01-10 대한민국 아동지킴이 과속방지시설

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds

Also Published As

Publication number Publication date
GR3029834T3 (en) 1999-06-30
MA22477A1 (fr) 1992-10-01
NO933425D0 (no) 1993-09-24
AU1426092A (en) 1992-11-02
ES2129039T3 (es) 1999-06-01
AP9200369A0 (en) 1992-04-30
CA2106880A1 (en) 1992-09-28
DE69228142D1 (de) 1999-02-25
JP3122792B2 (ja) 2001-01-09
DK0509974T3 (da) 1999-08-30
WO1992017477A1 (en) 1992-10-15
MX9201324A (es) 1992-10-01
AU655634B2 (en) 1995-01-05
IE920915A1 (en) 1992-10-07
ZA921823B (en) 1992-11-25
FI934203A (fi) 1993-09-24
AP309A (en) 1994-01-13
TNSN92026A1 (fr) 1993-06-08
ATE175672T1 (de) 1999-01-15
DE69228142T2 (de) 1999-07-22
EP0509974A1 (en) 1992-10-21
EP0580616A1 (en) 1994-02-02
CN1067892A (zh) 1993-01-13
FI934203A0 (fi) 1993-09-24
EP0509974B1 (en) 1999-01-13
NO933425L (no) 1993-10-25
JPH06506448A (ja) 1994-07-21
JO1704B1 (en) 1992-12-15
TW198032B (ja) 1993-01-11
HUT65948A (en) 1994-08-29
HU9302741D0 (en) 1993-12-28
IL101347A0 (en) 1992-11-15
US5439917A (en) 1995-08-08
SE9100920D0 (sv) 1991-03-27
YU30292A (sh) 1995-01-31
IS3827A (is) 1992-09-28
BG98124A (en) 1994-11-15
NZ241943A (en) 1993-12-23

Similar Documents

Publication Publication Date Title
SK103093A3 (en) New active compounds
RU2238271C2 (ru) Производные имидазопиридина, способы их получения и промежуточные соединения, фармацевтический препарат на их основе (варианты), способ ингибирования секреции желудочной кислоты, способ лечения желудочно-кишечных воспалительных заболеваний и способ лечения состояний, в которых вовлечено инфицирование h.pylori
RU2193036C2 (ru) Производные имидазо[1,2-а]пиридина, способы их получения, фармацевтический препарат на их основе, способ ингибирования секреции желудочной кислоты, способ лечения желудочно-кишечных воспалительных заболеваний и способ лечения состояний, в которые вовлечено инфицирование h.pylori
RU2136682C1 (ru) Имидазопиридины, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
RU2167874C2 (ru) Производные хинолин-2(1н)-она, способы их получения, лекарственное средство и фармацевтическая композиция на их основе
US4714762A (en) Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof
US4616025A (en) Thiazolidine derivatives, process for the preparation and pharmaceutical compositions thereof
DE3614132A1 (de) 1,3-dihydro-2h-imidazo(4,5-b)chinolin-2-one, verfahren zu deren herstellung und diese verbindungen enthaltende, pharmazeutische mittel
JP2517725B2 (ja) １Ｈ，３Ｈ−ピロロ〔１，２−ｃ〕チアゾ−ル誘導体、その製造法および薬としての用途
KR100339059B1 (ko) 이미다조[1,2-a]피리딘의알콕시알킬카르바메이트
JP2008514729A (ja) スピロ−ヒダントイン化合物の結晶形および製造方法
JPS623153B2 (ja)
NO311672B1 (no) Nye forbindelser, farmasöytisk preparat inneholdende slike forbindelser, deres anvendelser, og fremgangsmåter for deresfremstilling
HU191895B (en) Process for producing 2-guanidino-4-imidazolyl-thiazoles
SK197A3 (en) Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
JP3269658B2 (ja) フェノール誘導体
KR102465988B1 (ko) 항암, 항염증 효능을 가진 삼원환의 약학적 조성물
JPH07101941A (ja) ２−［２−（置換アミノ）ベンジルチオ］−５，６， ７，８−テトラヒドロ−４（３ｈ）−キナゾリノン誘 導体
JP3504972B2 (ja) ２−［２−（置換アミノ）ベンジルチオ］−５，６，７，８−テトラヒドロピリド［３，４−ｄ］ピリミジン−４（３Ｈ）−オン誘導体
FR2523972A1 (fr) Derives vinyliques substitues de la 1h-pyrazolo-(1,5-a) pyrimidine utiles notamment comme medicaments antiulcerigenes et antisecretoires gastriques et procede de leur preparation
JPH0220609B2 (ja)
JPH0525170A (ja) ピリドン誘導体、その製造法及びそれを含有する抗潰瘍剤
JPH10505331A (ja) ベンジルイミダゾピリジン
JPS61118386A (ja) トリアゾロキノリン誘導体
JPS5883681A (ja) ４−シクロアルキルアミノキナゾリン誘導体